Helsen C - Search Results

1

The genomic landscape of prostate cancer.

Spans L, Clinckemalie L, Helsen C, Vanderschueren D, Boonen S, Lerut E, Joniau S, Claessens F. Spans L, et al. Among authors: helsen c. Int J Mol Sci. 2013 May 24;14(6):10822-51. doi: 10.3390/ijms140610822. Int J Mol Sci. 2013. PMID: 23708091 Free PMC article. Review.

2

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling.

Claessens F, Denayer S, Van Tilborgh N, Kerkhofs S, Helsen C, Haelens A. Claessens F, et al. Among authors: helsen c. Nucl Recept Signal. 2008 Jun 27;6:e008. doi: 10.1621/nrs.06008. Nucl Recept Signal. 2008. PMID: 18612376 Free PMC article. Review.

3

A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels.

Tanner TM, Denayer S, Geverts B, Van Tilborgh N, Kerkhofs S, Helsen C, Spans L, Dubois V, Houtsmuller AB, Claessens F, Haelens A. Tanner TM, et al. Among authors: helsen c. Cell Mol Life Sci. 2010 Jun;67(11):1919-27. doi: 10.1007/s00018-010-0302-1. Epub 2010 Feb 26. Cell Mol Life Sci. 2010. PMID: 20186458

4

The rules of DNA recognition by the androgen receptor.

Denayer S, Helsen C, Thorrez L, Haelens A, Claessens F. Denayer S, et al. Among authors: helsen c. Mol Endocrinol. 2010 May;24(5):898-913. doi: 10.1210/me.2009-0310. Epub 2010 Mar 19. Mol Endocrinol. 2010. PMID: 20304998 Free PMC article.

5

Structural basis for nuclear hormone receptor DNA binding.

Helsen C, Kerkhofs S, Clinckemalie L, Spans L, Laurent M, Boonen S, Vanderschueren D, Claessens F. Helsen C, et al. Mol Cell Endocrinol. 2012 Jan 30;348(2):411-7. doi: 10.1016/j.mce.2011.07.025. Epub 2011 Jul 27. Mol Cell Endocrinol. 2012. PMID: 21801809 Review.

6

Identification and characterization of MEL-3, a novel AR antagonist that suppresses prostate cancer cell growth.

Helsen C, Marchand A, Chaltin P, Munck S, Voet A, Verstuyf A, Claessens F. Helsen C, et al. Mol Cancer Ther. 2012 Jun;11(6):1257-68. doi: 10.1158/1535-7163.MCT-11-0763. Epub 2012 Apr 10. Mol Cancer Ther. 2012. PMID: 22496481

7

Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor.

Helsen C, Dubois V, Verfaillie A, Young J, Trekels M, Vancraenenbroeck R, De Maeyer M, Claessens F. Helsen C, et al. Mol Cell Biol. 2012 Aug;32(15):3033-43. doi: 10.1128/MCB.00151-12. Epub 2012 May 29. Mol Cell Biol. 2012. PMID: 22645304 Free PMC article.

8

A role for selective androgen response elements in the development of the epididymis and the androgen control of the 5α reductase II gene.

Kerkhofs S, Dubois V, De Gendt K, Helsen C, Clinckemalie L, Spans L, Schuit F, Boonen S, Vanderschueren D, Saunders PT, Verhoeven G, Claessens F. Kerkhofs S, et al. Among authors: helsen c. FASEB J. 2012 Oct;26(10):4360-72. doi: 10.1096/fj.11-202283. Epub 2012 Jul 13. FASEB J. 2012. PMID: 22798427

9

The discovery of novel human androgen receptor antagonist chemotypes using a combined pharmacophore screening procedure.

Voet A, Helsen C, Zhang KY, Claessens F. Voet A, et al. Among authors: helsen c. ChemMedChem. 2013 Apr;8(4):644-51. doi: 10.1002/cmdc.201200549. Epub 2013 Feb 21. ChemMedChem. 2013. PMID: 23436650

10

The transcription intermediary factor 1β coactivates the androgen receptor.

Van Tilborgh N, Spans L, Helsen C, Clinckemalie L, Dubois V, Lerut E, Boonen S, Vanderschueren D, Claessens F. Van Tilborgh N, et al. Among authors: helsen c. J Endocrinol Invest. 2013 Oct;36(9):699-706. doi: 10.3275/8927. Epub 2013 Apr 8. J Endocrinol Invest. 2013. PMID: 23563173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page